Tampere University Biomedical Micro- and Nanodevices Master's Thesis Guide: 30 ECTS, BBT.MJS.111 and Trepo

Quick answer: what is the Biomedical Micro- and Nanodevices thesis route?

Tampere University’s Biomedical Micro- and Nanodevices option is a 120 ECTS Master of Science (Technology) route in Biomedical Sciences and Engineering. The current degree page explicitly states that the master’s thesis carries 30 ECTS, and the Technology thesis is graded 0-5.

The current field-specific advanced-studies anchor is BBTM.TEK-S26 Advanced Studies in Biomedical Micro- and Nanodevices, at least 80 ECTS. Thesis preparation uses BBT.MJS.111 Master’s Seminar, Biomedical Sciences and Engineering, 2 ECTS, pass/fail, whose 2026-2027 completion option explicitly includes Biomedical Micro- and Nanodevices students. Do not import CSEE’s ITC.CEE.800 into this Faculty of Medicine and Health Technology route.

1. Read the 120/80/30-credit objects correctly

Current Sisu exposes BSEM.BMN Biomedical Micro- and Nanodevices, at least 120 credits, and BBTM.TEK-S26 Advanced Studies in Biomedical Micro- and Nanodevices, at least 80 credits. Those labels must be interpreted inside the degree structure, not added together mechanically. The degree itself is 120 ECTS and separately states that the thesis carries 30 credits.

For your own plan, follow the Sisu structure attached to your admission cohort. The safe current thesis facts are the 30 ECTS Technology thesis and the BBT.MJS.111 seminar route.

2. What the specialisation actually covers

The specialization combines biomedical engineering with microsystems technology. Tampere lists microsensors, microactuators, microrobots, microfluidics, micro-optics, wearables, biosensors and wireless signal/power transfer. The advanced module expects students to design, model, simulate, test and apply microdevices and to understand microfabrication, microscale characterization and scaling effects.

That breadth does not mean one thesis must cover everything. A strong project chooses one bounded engineering contribution and then validates it at the correct evidence level.

3. Use BBTM.TEK-S26 as the advanced-studies anchor

BBTM.TEK-S26 is current through 2026-2027 and at least 80 ECTS. Its outcomes are especially useful for thesis planning: microsensor/actuator design, microfluidic and soft-robotic structures, fabrication-process choices, microscale characterization, implantable/body-centric antennas, RFID-based wireless power transfer and biomedical applications such as cell technologies and physiological measurements.

Treat these as subject capabilities, not a universal compulsory thesis checklist. Your exact course placement still comes from Sisu.

4. BBT.MJS.111 is the current thesis seminar

BBT.MJS.111 is a current 2 ECTS pass/fail master’s seminar run by the Faculty of Medicine and Health Technology. Its completion option explicitly lists Biomedical Micro- and Nanodevices. It develops understanding of thesis scope and process, presentation skills, scientific communication and familiarity with peer theses.

All parts of the completion option are compulsory. The route also contains a compulsory 0 ECTS pass/fail information-searching component. Keep this separate from the 30 ECTS thesis itself.

5. The thesis itself is 30 ECTS and graded 0-5

The Biomedical Sciences and Engineering degree page explicitly says the master’s thesis carries 30 credits. As an MSc (Technology) thesis it follows Tampere’s Technology process: supervision plan, preliminary examination, originality checking, final deposit in Trepo and formal examination. The thesis grade is 0-5, whereas BBT.MJS.111 is pass/fail.

A project may be academic, industrial or hospital-oriented. That context can shape the topic, but it does not relax research transparency or the public-thesis rules.

6. Start with a bounded device claim

Avoid topics such as “develop a biosensor” or “make an organ-on-chip” unless the claim is narrowed. Define what changes, compared with what, under which operating conditions, and which metric will decide whether the design worked. A thesis can contribute a fabrication process, device architecture, model, calibration method, measurement system or biomedical validation.

The title should not promise clinical benefit when the project only demonstrates bench performance. Write the evidence level into the question from the beginning.

7. Separate simulation, fabrication, bench testing and biomedical validation

These are different evidence layers. A COMSOL model can support a modelling claim; a fabricated chip can support manufacturability; calibrated bench data can support engineering performance; cell or physiological experiments can support a bounded biomedical-model claim. None automatically proves the next level.

Structure results so the reader can see where each conclusion comes from. This is especially important when a thesis moves from CAD/FEM to cleanroom fabrication and then into biological testing.

8. Microfabrication needs process traceability

Current BBT.MND.704 Microfabrication covers cleanroom practice, lithography/resist work, etching, deposition, wafer-level defects and yield, bonding, dicing and basic sample characterization. A thesis using these processes should record substrate, mask/layout revision, resist/process recipe, equipment, critical parameters and post-processing that influence outcome.

Track fabrication run and device identifiers. If yield or defect distribution affects the claim, report it rather than presenting only the best device.

9. Microsensor validation requires calibration, noise and drift

Current BBT.MND.701 Microsensors covers integrated sensor design, fabrication techniques, physical/chemical sensor types, noise, modelling and scientific reporting. For a sensor thesis, define calibration procedure, reference standard, measurement range, sensitivity, resolution or limit of detection when relevant, repeatability and drift.

Do not compare two sensors using different ranges, preprocessing or averaging rules without explaining the difference. Separate raw signal conditioning from the intrinsic sensor response.

10. Microfluidics: geometry and boundary conditions are part of the method

Current BBT.MND.702 Microfluidics covers fluid mechanics, capillarity, plug flow, polymer microcomponent fabrication, pumps/valves/mixers, COMSOL/MATLAB modelling and flow characterization. For a thesis, channel dimensions, materials, surface treatment, fluid properties, flow-driving method, temperature and boundary conditions may all matter.

If using FEM, document mesh strategy, material properties, solver settings and convergence/validation logic. Compare model outputs with measurements when the claim requires real-device performance.

11. Biosensor claims need three layers

Current BBT.MND.709 Biosensors covers molecular recognition, electrodes, optical sensors, intracellular sensors, SPR, miniaturization and biocompatibility. A biosensor thesis often has three linked but distinct layers: recognition chemistry, transducer/device performance and performance in the actual sample matrix.

A strong calibration identifies analyte range, matrix, reference method, interference conditions and replicate structure. Performance in buffer should not be reported as equivalent to performance in serum, tissue, cells or on-body use unless validated there.

12. Organ-on-chip evidence is model-level evidence

Tampere explicitly links the specialization to organ-on-chip systems. If your chip contains cells, report cell source, passage or relevant biological state, extracellular matrix/coating, seeding density, culture duration, perfusion/flow conditions and functional endpoints as applicable.

An organ-on-chip can model a mechanism or response under controlled conditions. It does not by itself establish patient-level effectiveness, toxicity or treatment benefit. State what the model represents and what it does not.

13. Microactuator and soft-device studies need dynamic metrics

For microactuators, microrobots or soft structures, a static displacement value is rarely enough. Depending on the claim, record drive conditions, force/displacement, response time, hysteresis, repeatability, fatigue/cycle behaviour and environmental conditions. If the device operates in fluid, tissue-like media or at body-relevant temperatures, report those conditions.

Separate actuator-material behaviour from complete-system behaviour so failure mechanisms remain interpretable.

14. Wearables and physiological sensing: engineering accuracy is not clinical utility

The programme points to wearable monitoring and physiological measurement applications. A wearable thesis should define reference instrumentation, placement, sampling, synchronization, motion/context effects and participant/session structure. If algorithms are involved, prevent subject or session leakage between training and evaluation.

A device can show engineering agreement with a reference without proving diagnostic accuracy or clinical utility. Use terminology that matches the study design.

15. Wireless power and RFID claims need realistic loading conditions

BBTM.TEK-S26 includes implantable/body-centric antennas and RFID-based wireless power transfer. A thesis in this area should separate electromagnetic simulation, phantom/bench measurements and actual on/in-body evidence. Geometry, frequency, matching, orientation, distance and surrounding material/loading can materially affect results.

Do not report free-space performance as body-centric performance without the corresponding validation.

16. Experimental unit and replicate structure

A wafer containing many devices does not automatically provide many independent fabrication replicates, and repeated readings from one sensor do not create independent devices. Define the experimental unit at the level of the claim: wafer, fabrication run, device, chip, cell culture, participant or session.

Use nested or repeated-measures analysis when the data hierarchy requires it. State technical repeats separately from independent units.

17. Batch, run and day effects can dominate small devices

Micro/nanodevice results can shift with wafer lot, mask revision, fabrication run, surface treatment, device packaging, reagent lot, cell passage or measurement day. Track these variables before analysis. If only one run is available, acknowledge the limitation rather than generalizing to manufacturing reproducibility.

Randomization or blocking across runs can make comparisons stronger when practical.

18. Controls and baselines must test the claim

Choose controls that reveal whether the claimed mechanism is plausible. Examples include blank chips, commercial/reference sensors, known calibration standards, sham flow conditions, no-recognition-element controls, positive/negative biological controls, or a simpler simulation/model baseline.

A sophisticated prototype compared only with itself cannot establish superiority. Define the baseline before data collection when possible.

19. Microscopy and image analysis need an audit trail

Microstructures and cell-chip systems often rely on microscopy. Preserve acquisition settings, scale calibration, exposure/focus rules, image selection criteria, segmentation thresholds and any manual corrections. If many fields of view come from one chip or culture, do not treat every image as an independent sample.

Keep representative images separate from quantitative sampling rules.

20. Failure analysis is part of engineering evidence

A failed fabrication run, leaking microchannel, delaminated bond, saturated sensor or drifting baseline can be scientifically useful if documented. Classify failure modes and connect them to process or design variables when evidence allows. Avoid deleting inconvenient devices without a predefined exclusion rule.

Reporting only successful prototypes biases the engineering story and hides manufacturability limits.

21. Human cells, tissues and participant-derived measurements

If the project uses human cells, tissues, participant-derived samples or physiological measurements, establish the applicable ethical review, consent/permission, data-protection and sample-governance route before use. Access to a sample or dataset does not itself prove authorization for a student thesis.

Document what material/data was used and the governance relevant to reproducibility without disclosing identifying or restricted information.

22. Animal research has its own legal and ethical route

If the thesis involves animals or animal-derived work under regulated conditions, follow the applicable legal and institutional approvals. Do not assume that an existing laboratory project automatically covers a new student protocol or a changed endpoint.

If the thesis only analyses already-generated data, document the provenance and permissions for secondary use.

23. Personal data and coded biomedical data

Wearable studies, physiological measurements, patient-linked samples or coded metadata may involve personal data even when names are removed. Follow Tampere’s thesis data-protection guidance, define controller/processing roles where applicable, minimize data and control access.

Do not upload personal, confidential or unpublished device data to external AI services unless the applicable rules permit it.

24. Cleanroom, electrical and biosafety are method quality

Micro/nanodevice theses may combine cleanroom chemicals, plasma/etch/deposition equipment, lasers/microscopy, electrical systems, biological samples and microfluidic pressure. Follow the hosting laboratory’s approved procedures, training and waste rules rather than improvising safety from the thesis text.

Safety-related process deviations can also change scientific results, so record them when they affect comparability.

25. Reproducibility: connect CAD to the final figure

Create a traceability chain from CAD/layout revision to wafer/run/device identifier, fabrication recipe, calibration file, raw data, processing script and final figure. Version simulation models, code and analysis parameters. Record software and instrument versions when they can change results.

This makes it possible to distinguish a genuine design effect from a run-specific accident or analysis change.

Before the final analysis, run a device-evidence audit. For microfabrication work, verify that every tested chip can be traced to its fabrication run and that the reported microfabrication parameters correspond to the actual device rather than an intended recipe. For microfluidics, preserve the geometry revision, fluid properties, pressure/flow settings, simulation inputs and raw measurement files. For biosensor work, preserve calibration standards, matrix composition, recognition-element preparation, reference measurements and the calculation used for sensitivity or detection limits. These checks prevent later ambiguity when several device versions were tested during development.

Also distinguish development data from final evaluation data. It is acceptable to use early chips to tune microfabrication, microfluidics or biosensor protocols, but the thesis should make clear which data informed design choices and which data provide the final evidence for the stated claim. If a threshold, exclusion criterion or analysis rule was changed after inspecting results, document the change and explain why. This is particularly important for small sample sizes, where one device or one fabrication run can strongly affect the conclusion.

Finally, keep negative evidence. A microfluidic design that leaks at a defined pressure, a biosensor that loses selectivity in a complex matrix, or a microfabrication process with low yield may be the most useful engineering result in the project. A defensible thesis explains these limits and narrows the claim instead of hiding them.

26. AI use: protect data and verify scientific content

Tampere permits AI support under current study guidance, but the student remains responsible for the work. Agree thesis-specific AI principles with the primary supervisor and follow acknowledgement rules.

Do not upload confidential laboratory data, unpublished partner results, patient/participant information or protected material to external AI services without an approved basis. Verify AI-generated literature summaries, citations, equations, code and biological explanations against primary sources and your own analysis.

27. Supervision plan and project dependencies

Technology thesis students prepare a Thesis Supervision Plan with the supervisor. Use it to define scope, meeting practices, milestones and responsibilities. For BTE, also record dependencies such as cell/material availability, ethics/permission timing, laboratory access, shared equipment, long culture periods and assay lead times.

Have a fallback plan. If a cell source fails or an instrument becomes unavailable, decide whether the thesis can answer a narrower question using existing data, alternative characterisation or a literature/computational route.

28. Writing while experiments are running

Write methods while protocols are still fresh. Maintain a results ledger linking every figure to the experimental question. Separate observations from interpretation: first describe what changed, then discuss the mechanism and competing explanations.

A negative or null result can still be a valid thesis result if the study was well designed. Do not silently remove unfavourable batches or endpoints. Explain exclusions using pre-defined or scientifically defensible criteria.

29. Maturity test, Turnitin, Trepo and PDF/A

A maturity test is part of the master’s-thesis process. For international master’s students in Technology, Tampere’s current guidance states that the thesis abstract serves as the maturity test, with content assessed by the examiner; students with a different language route should follow the applicable current instructions.

After primary-supervisor permission, the final thesis goes through Turnitin and supervisor review, then is deposited in Trepo for formal examination. The student must be registered as attending to submit and receive credits. Prepare the final file as valid PDF/A for permanent archiving.

30. Examination, grading and timing

The Technology thesis is graded 0-5. Tampere’s normal examiner window is 21 days, extended to 28 days when a separate maturity test is required as part of the process. These are assessment windows, not guarantees for the whole graduation process.

The examiner statement and proposed result are sent to the student’s tuni.fi email. Plan backwards from graduation deadlines and leave time for preliminary review, revisions, Turnitin, Trepo access and faculty processing.

31. Final Biomedical Micro- and Nanodevices checklist

Before submission, verify five layers. Curriculum: 30 ECTS thesis, current BBT.MJS.111 completion, and your own Sisu structure. Engineering evidence: design revision, simulation assumptions, fabrication run, calibration and device identifiers are traceable. Biomedical evidence: the model, sample/participant context and approvals match the claim. Analysis: experimental units, baselines, uncertainty and exclusions are explicit. Submission: AI use, Turnitin, maturity, Trepo/PDF-A, publicity and examiner timing are handled under current Tampere instructions.

A defensible BMND thesis is not the device with the most features. It is the project whose evidence chain is clear from design and fabrication to the exact conclusion being claimed.

Before freezing the manuscript, perform one last cross-layer verification. Check that the CAD or model revision named in Methods is the same revision that entered microfabrication; that the fabricated device identifier matches the calibration and raw-data files; that microfluidics or biosensor preprocessing is identical across compared groups unless a justified difference is documented; and that every figure can be traced back to an analysis script, notebook entry or controlled manual procedure. Re-run key calculations from raw data where practical. Confirm units, axis scales, calibration equations and uncertainty definitions independently. If a result depends on one fabrication run, one chip, one participant or one biological batch, say so prominently rather than letting a reader infer broader replication. Finally, read every biomedical or clinical-sounding sentence and ask whether the evidence is actually device-level, model-level, participant-level or clinical. Tightening those final sentences often improves the scientific quality more than adding another experiment.